According to the latest report by IMARC Group, The global albumin market size reached US$ 5.4 Billion in 2021. Albumin refers to a water-soluble globular protein produced by the liver and found in blood plasma. It enters the bloodstream and prevents fluids from leaking out of the blood vessels into other tissues. It also maintains the blood volume, regulates intravascular colloid osmotic pressure (COP), and carries hormones, vitamins, and enzymes throughout the body.

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Albumin
Market Research
Report 2022-2027
Author: Elena Anderson
Marketing Manager
IMARC Group
© 2022 IMARC All Rights Reserved

2. Report Description
About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all regions
and industry verticals to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Albumin Market Outlook 2022-2027:
The latest report by IMARC Group, titled “Albumin Market: Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2022-2027,” finds that the global albumin market size reached
US$ 5.4 Billion in 2021.
Albumin refers to a water-soluble globular protein produced by the liver and found in blood plasma.
It enters the bloodstream and prevents fluids from leaking out of the blood vessels into other tissues.
It also maintains the blood volume, regulates intravascular colloid osmotic pressure (COP), and carries
hormones, vitamins, and enzymes throughout the body.
It is widely used as a blood volumizer to treat rare diseases, liver disorders, blood loss, shocks,
surgical complications, and burns. Besides this, albumin finds extensive applications in manufacturing
drug delivery systems, therapeutics, culture media, and vaccines.
Request for a PDF sample of this report: https://www.imarcgroup.com/albumin-
market/requestsample

4. Report Description
Report Description and Highlights
Global Albumin Market Drivers/Constraints:
Albumin is extensively utilized for treating renal dialysis, liver failure, hypovolemia, acute respiratory
distress syndrome, cardiopulmonary disorders, nephrosis, and hypoalbuminemia. As a result, the
surging prevalence of chronic diseases represents the primary factor driving the market growth.
Moreover, the expanding geriatric population that is more prone to developing such medical ailments is
positively influencing the market growth.
Furthermore, albumin is rapidly gaining traction as a pharmaceutical stabilizer to reduce the
denaturation of protein-active ingredients. In line with this, the growing usage of human serum albumin
(HSA) to replenish proteins in human plasma and regulate plasma colloid oncotic pressure has
augmented the product demand.
Apart from this, the rising adoption of HSA in pharmaceutical preparations, such as drug formulations
and vaccines, is another major growth-inducing factor. In addition, the introduction of albumin-based
nanoparticles and extensive investments in drug development and drug discovery activities in the
biopharmaceutical industry have catalyzed market growth.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/albumin-market

5. Report Description
Report Description and Highlights
Key Market Segmentation
The research report includes the following segments:
Breakup by Product:
• Human Serum Albumin
• Bovine Serum Albumin
• Recombinant Albumin
Breakup by Application:
• Therapeutics
• Drug Formulation and Vaccine
• Component of Media

6. Report Description
Report Description and Highlights
Breakup by End User:
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Research Institutes
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2027, exhibiting a
CAGR of 6.15% during 2022-2027.

7. Report Description
Report Description and Highlights
Competitive Landscape:
• Albumedix Ltd
• Biotest AG
• Celgene Corporation (Bristol-Myers Squibb Company)
• CSL Limited
• Grifols SA
• HiMedia Laboratories
• Medxbio Pte Ltd
• Merck KGaA
• Octapharma AG
• Takeda Pharmaceutical Company Limited
• Thermo Fisher Scientific Inc
• Ventria Bioscience Inc
Note: We are updating our reports, If you want the report with the latest primary and secondary
data (2022-2027) including industry trends, market size and Competitive landscape, etc.
Click here: https://www.imarcgroup.com/albumin-market/requestsample

8. Report Description
Key Questions Answered in the Report
1. What has been the historical growth rate of the global Albumin Market?
2. What has been the impact of COVID-19 on the global Albumin Market?
3. What are the key factors driving the global Albumin Market?
4. What is the breakup of the global Albumin Market based on the type?
5. What is the breakup of the global Albumin Market based on the application?
6. What is the breakup of the global Albumin Market based on the distribution channel?
7. What are the key regions in the global Albumin Market?
8. Who are the key players/companies in the global Albumin Market?

9. Report Description Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends

10. Report Description Table of Contents
5 Global Albumin Market Industry
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product
5.5 Market Breakup by Application
5.6 Market Breakup by End User
5.7 Market Breakup by Region
Click here to visit the complete table of content with list of figures and tables:
https://www.imarcgroup.com/albumin-market/toc

11. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

12. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

13. Report Description
Report Description and Highlights
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

14. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us